Werewolf Therapeutics Stock (NASDAQ: HOWL) stock price, news, charts, stock research, profile.
Open | $2.09 |
Close | $2.14 |
Volume / Avg. | 170.57K / 295.89K |
Day Range | 2.01 - 2.28 |
52 Wk Range | 1.57 - 8.19 |
Market Cap | $91.69M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 1.92% |
Days to Cover | 1.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Werewolf Therapeutics (NASDAQ:HOWL) through any online brokerage.
Other companies in Werewolf Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for Werewolf Therapeutics.
Werewolf Therapeutics has a consensus price target of $13.90.
The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $2.1099 last updated July 3, 2024 at 9:24 AM EDT.
There are no upcoming dividends for Werewolf Therapeutics.
Werewolf Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Werewolf Therapeutics.
Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.